On Invalid Date, Disc Medicine (NASDAQ: IRON) reported Q2 2024 earnings per share (EPS) of -$1.03, up 39.19% year over year. Total Disc Medicine earnings for the quarter were -$26.35 million. In the same quarter last year, Disc Medicine's earnings per share (EPS) was -$0.74.
As of Q3 2024, Disc Medicine's earnings has grown year over year. Disc Medicine's earnings in the past year totalled -$91.00 million.
What is IRON's earnings date?
Disc Medicine's earnings date is Invalid Date. Add IRON to your watchlist to be reminded of IRON's next earnings announcement.
What was IRON's revenue last quarter?
On Invalid Date, Disc Medicine (NASDAQ: IRON) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Disc Medicine's revenue was $0.00.
What was IRON's revenue growth in the past year?
As of Q3 2024, Disc Medicine's revenue has grown null year over year. Disc Medicine's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.